Physician
Hematology
Dr. Eric W. Bleickardt, MD
|
|
Give Review
Dr. Eric W. Bleickardt practices Hematology. He attended Rutgers Robert Wood Johnson Medical School. Rutgers Robert Wood Johnson Medical School is ranked 74 in research and 67 in primary care medicine Eric W. Bleickardt, MD is a published doctor as well. He has 10 publications published. The latest was: Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia.
Publications
- National Oncology Forum: perspectives for the year 2000.
- Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia.
- Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily: two-year follow-up of a rand...
- Dasatinib early intervention after cytogenetic or hematologic resistance to imatinib in patients with chronic myeloid leukemia.
- Transient potent BCR-ABL inhibition is sufficient to commit chronic myeloid leukemia cells irreversibly to apoptosis.
- Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chroni...
- Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias.
- Phase I dose escalation trial of weekly docetaxel plus irinotecan in patients with advanced cancer.
- Camptothecin and taxane regimens for small-cell lung cancer.
Schools
University of Medicine And Dentistry of New Jersey Robert Wood Johnson Medical School
Beth Isreal Deaconess Med Center
Beth Israel Med Center
Yale New Haven Med Center Yale University
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Education
-
Beth Israel Deaconess Medical Center -
Rutgers Robert Wood Johnson Medical School
Helpful Reviews
Similar Doctors
|
|
Dr. David S. Fischer, MD |
|
|
Dr. Patrick R. Duffy, MD |
|
|
Dr. Mark M. Brook, MD |
|
|
Dr. Ian B. Walters, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|